Scaffold-seeded oral mucosa stem cells
AssigneesRamot at Tel-Aviv University Ltd., Technion Research & Development Foundation Limited
InventorsShulamit LEVENBERG, Sandu PITARU, Daniel OFFEN, Javier Ganz, Sivan Ida COHEN-MATSLIAH, Erez SHOR
Life of this patent
Estimating the term…
Abstract
A method of treating a spinal cord injury in a subject in need thereof is disclosed. The method comprises implanting a scaffold into the spinal cord of a subject, wherein the scaffold is seeded with oral mucosa stem cells (OMSC) and/or cells that have been ex vivo differentiated from said OMSCs, thereby treating the spinal cord injury.
Claims28
A method of treating a spinal cord injury in a subject in need thereof comprising implanting a scaffold into the spinal cord of a subject, wherein the scaffold is seeded with oral mucosa stem cells (OMSC) and/or cells that have been ex vivo differentiated from said OMSCs, thereby treating the spinal cord injury.
A scaffold comprising oral mucosa stem cells (OMSC) and/or cells that have been ex vivo differentiated from said OMSCs.
(canceled)
(canceled)
8-10. (canceled)
12-15. (canceled)
(canceled)
Dependencies are inferred from the claim text.